CIM
Contravisory Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.3M | Buy |
136,127
+268
| +0.2% | +$12.4K | 1.24% | 39 |
|
|
2025
Q1 | $8.29M | Buy |
135,859
+127,239
| +1,476% | +$7.76M | 1.75% | 23 |
|
|
2024
Q4 | $488K | Buy |
+8,620
| New | +$488K | 0.1% | 140 |
|
|
2023
Q2 | – | Sell |
-4,677
| Closed | -$324K | – | 305 |
|
|
2023
Q1 | $324K | Hold |
4,677
| – | – | 0.09% | 153 |
|
|
2022
Q4 | $337K | Buy |
+4,677
| New | +$337K | 0.09% | 150 |
|
|
2020
Q3 | – | Sell |
-3,601
| Closed | -$205K | – | 254 |
|
|
2020
Q2 | $205K | Buy |
+3,601
| New | +$205K | 0.08% | 149 |
|
|
2018
Q1 | – | Sell |
-159
| Closed | -$10K | – | 345 |
|
|
2017
Q4 | $10K | Buy |
159
+59
| +59% | +$3.71K | ﹤0.01% | 268 |
|
|
2017
Q3 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 288 |
|
|
2016
Q3 | – | Sell |
-31
| Closed | -$2K | – | 284 |
|
|
2016
Q2 | $2K | Hold |
31
| – | – | ﹤0.01% | 156 |
|
|
2016
Q1 | $2K | Hold |
31
| – | – | ﹤0.01% | 146 |
|
|
2015
Q4 | $2K | Buy |
+31
| New | +$2K | ﹤0.01% | 150 |
|
|
2014
Q3 | – | Sell |
-183,319
| Closed | -$8.89M | – | 149 |
|
|
2014
Q2 | $8.89M | Sell |
183,319
-8,183
| -4% | -$397K | 1.76% | 38 |
|
|
2014
Q1 | $9.95M | Buy |
+191,502
| New | +$9.95M | 1.95% | 32 |
|